Inhibition of cellular RNA methyltransferase abrogates influenza virus capping and replication

Affiliations

• 1 Institute of Cardiovascular Immunology, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.
• 2 International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Hokkaido, Japan.
• 3 Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.
• 4 Division of Risk Analysis and Management, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Hokkaido, Japan.
• 5 One Health Research Center, Hokkaido University, Sapporo, Hokkaido, Japan.
• 6 Institute of Virology Muenster, Westfaelische Wilhelms-University, Muenster, Germany.
• 7 CiM-IMPRS, Westfaelische Wilhelms-University Muenster, International Max Planck Research School - Molecular Biomedicine, Muenster, Germany.
• 8 PharmaCenter Bonn and Pharmaceutical Institute, Pharmaceutical and Medicinal Chemistry, University of Bonn, Bonn, Germany.
• 9 Institute of Virology, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.
• 10 Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
• 11 Institute of Innate Immunity, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.
• 12 Institute of Clinical Chemistry and Clinical Pharmacology, Medical Faculty, University Hospital Bonn, Bonn, Germany.
• 13 Department of Oncology, Hematology, Rheumatology and Immune-Oncology, University Hospital Bonn, University of Bonn, Bonn, Germany.
• 14 Institute of Immunology, Philipps-University Marburg, Marburg, Germany.
• 15 Department of Biomedicine, Aarhus University, Aarhus, Denmark.
• 16 Transborder Medical Research Center, University of Tsukuba, Tsukuba, Japan.
• 17 Division of Biomedical Science, University of Tsukuba, Tsukuba, Japan.
• 18 Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology, Tokyo, Japan.
• 19 Core Facility Nanobodies, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.
• 20 Institute of Virology, Medical Center, University of Freiburg, Freiburg, Germany.
• 21 Faculty of Medicine, University of Freiburg, Freiburg, Germany.
• 22 Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
• 23 Neuroscience Program of Academia Sinica, Academia Sinica, Taipei, Taiwan.
• 24 Institute of Virology, School of Medicine, Technical University of Munich, Munich, Germany.
• 25 German Center for Infection Research (DZIF), Munich Partner Site, Munich, Germany.
• 26 German Center for Infection Research (DZIF), partner site Bonn-Cologne, Bonn, Germany.
• 27 Interdisciplinary Center for Medical Research, Medical Faculty Muenster, Germany.
• 28 Division of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Hokkaido, Japan.